Bipolar disorder and attention deficit hyperactivity disorder;Trouble bipolaire et trouble déficit d'attention avec hyperactivité

Annales Medico-Psychologiques

Volumn 167, Issue 10, 2009, Pages 810-813

  Besnier, N ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Attention Deficit Hyperactivity Disorder; Bipolar Disorder; Mood Stabilizers; Psychostimulants

Indexed keywords

METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISTRACTIBILITY; EMOTIONAL DISORDER; HUMAN; IMPULSIVENESS; IRRITABILITY; MOOD DISORDER; PRESCRIPTION; RESTLESSNESS;

EID: 70450221498     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amp.2009.09.004     Document Type: Article

References (24)

1. Biederman J., Faraone S.V., Spencer T., et al. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 53 (1994) 13-29
2. Biederman J., Makris N., Valera E.M., et al. Towards future understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: A MRI study of brain volumes. Psychol Med 38 (2007) 1045-1056
3. Castaneda R., Levy R., Hazzi C., et al. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients. Gen Hosp Psychiatry 30 (2008) 572-577
4. Conners C.K., Erhardt D., and Sparrow E. Conners Adult ADHD Rating Scale, technical manual (1999), Multi-Health Systems, New York
5. Delbello M.P., Soutullo C.A., Hendricks W., et al. Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 3 (2001) 53-57
6. Gibson A.P., Bettinger T.L., Patel N.C., et al. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann Pharmacother 40 (2006) 1134-1142
7. Guyer A., McClure E., Adler A., et al. Specificity of facial expression labeling deficits in childhood psychopathology. J Child Psychol Psychiatry 48 (2007) 863-871
8. Lopez-Larson M., Michael E.S., Terry J.E., et al. Subcortical differences among youths with attention-deficit/hyperactivity disorder compared to those with bipolar disorder with and without attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19 (2009) 31-39
9. Lydon E., and El-Mallakh R.S. Naturalistic long-term use of methylphenidate in bipolar disorder. J Clin Psychopharmacol 26 (2006) 516-518
10. Milberger S., Biederman J., Faraone S.V., et al. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry 152 (1995) 1793-1799
11. Millstein R.B., Wilens T.E., Biederman J., et al. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Atten Disord 2 (1997) 159-166
12. Nierenberg A.A., Miyahara S., Spencer T., et al. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 57 (2005) 1467-1473
13. Rucklidge J. Impact of ADHD on the neurocognitive functioning of adolescents with bipolar disorder. Biol Psychiatry 60 (2006) 921-928
14. Soutullo C.A., Chang K.D., Diez-Suarez A., et al. Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology. Bipolar Disord 7 (2005) 497-506
15. Soutullo C.A., DelBello M.P., Ochsner J.E., et al. Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord 70 (2002) 323-327
16. Spencer T., Biederman J., Wilens T., et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 456-463
17. State R.C., Frye M.A., Altshuler L.L., et al. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. J Clin Psychiatry 65 (2004) 1057-1063
18. Tamam L., Karakus G., and Ozpoyraz N. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci 258 (2008) 385-393
19. Wender P.H., Wolf L.E., and Wasserstein J. Adults with ADHD: An overview. Ann N Y Acad Sci 931 (2001) 1-16
20. Wilens T.E., Biederman J., Wozniak J., et al. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry 54 (2003) 1-8
21. Wilens T.E., Prince J.B., Spencer T., et al. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry 54 (2003) 9-16
22. Wilens T.E., Spencer T.J., Biederman J., et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158 (2001) 282-288
23. Wingo A.P., and Ghaemi S.N. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients. Psychopharmacol Bull 41 (2008) 37-47
24. Winokur G., Coryell W., Endicott J., et al. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry 150 (1993) 1176-1181